SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community speculates on potential catalysts and price movements, with some eyeing previous cycle highs. Discussions range from the possibility of a spot ETF to general market sentiment, while others express frustration with the current price action. The crypto community remains divided between bullish predictions and bearish concerns amid broader market uncertainty.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as traders discuss its potential breakout and strong performance relative to other cryptocurrencies. Community members are pointing to bullish formations on the LTC/BTC chart, anticipating a significant price movement. There's also discussion around ETF inflows and Litecoin's role in broader crypto adoption.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending due to renewed interest in privacy coins, spurred by endorsements from figures like Arthur Hayes and accumulation by Cypherpunk Technologies. The community is discussing ZEC's potential as a hedge against Bitcoin and its possible surge to new all-time highs, while others caution against the pump and dump and urge caution.

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Amicus Therapeutics Inc

Amicus Therapeutics ($FOLD) is trending as investors analyze its potential following positive analyst ratings and anticipation for key milestones. Discussions center on the company's growth prospects, particularly the upcoming FDA decision, and the potential impact on the company's long-term valuation. The community speculates about a possible acquisition, with some suggesting that the company's current position makes it an attractive target for larger pharmaceutical companies.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto (GLTO) is trending due to its acquisition of Damora Therapeutics and a concurrent private placement, which has sparked significant volatility and bullish sentiment. The community is actively discussing the potential for a short squeeze, citing the stock's low float and recent price surge, while warning of possible dilution and high risk.

BlackLine, Inc. engages in providing a cloud-based software platform that automates and controls financial close and accounting processes. It operates through the United States and International geographical segments. The company was founded by Therese Tucker in May 2001 and is headquartered in Woodland Hills, CA.

BlackLine Inc

BlackLine ($BL) is trending amid speculation of a potential takeover by a private equity firm, despite previously rejecting an offer from SAP. Community discussion revolves around the company's potential value and future strategic direction in the financial software sector. Bullish sentiment is building based on technical indicators and recent AI-powered platform advancements.

Liberty Energy, Inc. engages in the provision of hydraulic fracturing services to onshore oil and natural gas exploration for production companies in North America. The company was founded on December 21, 2016 and is headquartered in Denver, CO.

Liberty Energy Inc - Ordinary Shares - Class A

Recent messages indicate Liberty Energy ($LBRT) is trending due to discussions around market maker manipulation, analyst ratings, and its dividend. Community members are also focused on Liberty's unique position in the energy sector, particularly its involvement in power generation and partnerships like the one with $OKLO.

Appian Corp. engages in the provision of business process management (BPM) solutions. Its products include BPM software, case management, mobile application development, and platform-as-a-service. The company was founded by Matthew Wheeler Calkins, Robert Charles Kramer, Marc Wilson, and Michael Beckley in 1999 and is headquartered in McLean, VA.

Appian Corp - Ordinary Shares - Class A

Appian ($APPN) is trending as the community discusses its "allergy" to the $46 price level and potential trading strategies around this resistance. Despite strong bullish momentum indicated by its moving averages, the stock's overbought RSI suggests a possible short-term pullback, influencing community sentiment.

Robert Half, Inc. engages in the provision of talent solutions and business consulting services. It operates through the following segments: Contract Talent Solutions, Permanent Placement Talent Solutions, and Protiviti. The Contract Talent Solutions segment refers to the fields of finance and accounting, technology, marketing and creative, legal, and administrative and customer support. The Permanent Placement Talent Solutions segment focuses on accounting, finance, tax, and accounting operations personnel. The Protiviti segment solves problems in finance, technology, operations, data, digital, legal, human resources, governance, risk, and internal audit. The company was founded by Robert Half in 1948 and is headquartered in Menlo Park, CA.

Robert Half Inc

Robert Half International Inc.

Robert Half ($RHI) is attracting attention as its stock price approaches its 60-day low, with its RSI nearing oversold territory. While trading below key moving averages signals a bearish trend, some investors believe the potential for a job market rebound makes it an attractive buy. However, analysts are cautious, pointing to workforce reductions and potential headwinds from AI, and recent ratings have been adjusted to neutral or sell.

Winnebago Industries, Inc. engages in the manufacture of recreational vehicles and marine products. It operates through the following business segments: Towable RV, Motorhome RV, and Marine. The Towable RV segment includes non-motorized vehicles that are designed to be towed by automobiles, pickup trucks, SUVs, and vans and are used as temporary living quarters for recreational travel. The Motorhome RV segment focuses on a self-propelled mobile dwelling used primarily as temporary living quarters during vacation and camping trips, or to support active and mobile lifestyles. The Marine segment is involved in the manufacturing and selling of recreational boats under the Chris-Craft and Barletta. The company was founded on February 12, 1958 and is headquartered in Eden Prairie, MN.

Winnebago Industries, Inc.

Winnebago (WGO) is trending as investors discuss options activity and a Truist Securities analyst upgrade. Bullish sentiment is building following positive updates and insider buying, while analysts adjust their stances on the stock. The community is also sharing insights into WGO's financials and broader market trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ARDX  
Ibsrela TRx 4 week change up. Total Patients(4 week total) at a record. On the chart I posted pretty close to the center of the bottom and middle fan line. 4 week change in TRx about the same as last week, below the average 4 week change since launch, but the 4 week average of that change, is still above the yearly average.  NRx weak. RRx strong. So scripts seem to be a little lumpy. Base for the next 2 weeks is strong so hopefully good numbers coming.  
 
Xphozah up on a 4 week basis. Not quite to the top of the recent range but Total Patients up near the top of the yearly range.

AC does research

Lenni

Orion Laverne

Dee Cee

MY PRONOUNS R NOT INV ADVICE

Wade Browning

EV Investor

Joel

Mike Raab

Rick

JustB

Noted

Andrea

opportoni

Maurizio (ita)

Dr. Zebra

Bob Cox

dIana

Gregory C Robinson

John

Woutje

Moon Shot

Sami Kauppinen

Jonathan Grauwickel

Reno Nautique

StockTwits Web

Ardelyx Inc

  
Ibsrela TRx 4 week change up. Total Patients(4 week total) at a record. On the chart I posted pretty close to the center of the bottom and middle fan line. 4 week change in TRx about the same as last week, below the average 4 week change since launch, but the 4 week average of that change, is still above the yearly average.  NRx weak. RRx strong. So scripts seem to be a little lumpy. Base for the next 2 weeks is strong so hopefully good numbers coming.  
 
Xphozah up on a 4 week basis. Not quite to the top of the recent range but Total Patients up near the top of the yearly range.

Robert

Piktoro

StockTwits For Android 

@Orion_Laverne @Burning_Cash @Cameohitch @bernardbaruch @Lenni_D @JustB4SnR1se @SpecialEdition @Paul_Volcker @Mrmadchemist  
You are welcome.

@M_OF_E   Wonderful  to  read,  Robert. Thank  you.

   Wonderful  to  read,  Robert. Thank  you.

@M_OF_E Thanks Roberto for the data, it looks like both drugs are well positioned with good momentum and an excellent Q4 is expected.

 Thanks Roberto for the data, it looks like both drugs are well positioned with good momentum and an excellent Q4 is expected.

CLAUDIO SCOCCIA

@fabio69  
You are welcome. Momentum is okay not great. But then again the Symphony scripts were like that in Q3 and Ibsrela revenue was a blowout. I do expect Q4 to be very good but only partially due to the scripts.

Shanae Gupta

  
You are welcome. Momentum is okay not great. But then again the Symphony scripts were like that in Q3 and Ibsrela revenue was a blowout. I do expect Q4 to be very good but only partially due to the scripts.

John Bowman

StockTwits for iOS

Zendera

@bams1017 @Cjs2027 @FerreroRocher @Ischia12 @Bobhanu  
You are welcome.